Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for WCIG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 0.0046M
March 31, 2026 0.0011M
September 30, 2025 0.0096M
June 30, 2025 0.0003M
March 31, 2025 0.0008M
September 30, 2024
December 31, 2023
September 30, 2023
June 30, 2023
March 31, 2023
December 31, 2022 0.0039M
September 30, 2022 -0.0128M
June 30, 2022 0.0025M
March 31, 2022 0.0369M
December 31, 2021 0.0153M
September 30, 2021 0.0343M
June 30, 2021 0.0747M
March 31, 2021 0.0171M
December 31, 2020
September 30, 2020 0.0002M
June 30, 2020 -0.1675M
March 31, 2020 0.1675M
December 31, 2019 0.0246M
September 30, 2019 0.0167M
June 30, 2019 0.0132M
Date Value
March 31, 2019 0.0108M
December 31, 2018 0.0059M
September 30, 2018 -0.0028M
June 30, 2018 0.0316M
March 31, 2018 0.0352M
December 31, 2017 0.0074M
September 30, 2017 0.0257M
June 30, 2017 -0.0164M
March 31, 2017 0.0376M
December 31, 2016 0.0002M
September 30, 2016 0.0272M
June 30, 2016 0.0257M
March 31, 2016 -0.0003M
December 31, 2015 0.0127M
September 30, 2015 0.012M
June 30, 2015 0.0282M
March 31, 2015 0.0272M
December 31, 2014 0.0197M
September 30, 2014 0.0343M
June 30, 2014 0.0533M
March 31, 2014 0.071M
December 31, 2013 0.0258M
September 30, 2013 0.0109M
June 30, 2013 0.0162M
March 31, 2013 0.0442M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Arcis Resources Corp. --
Altria Group, Inc. -1.831B
Philip Morris International, Inc. -4.765B
Universal Corp. 244.30M
BioRegenx, Inc. -0.0502M